Coagulase-negative staphylococci (CoNS) are among the most frequently recovered
bacteria in routine clinical care. Their incidence has steadily increased over the past …

Background: Infections by multi-drug-resistant (MDR) organisms are sharply increasing in
newborns worldwide. In low and middle-income countries, a disproportionate amount of …

Staphylococcus aureus is a human pathobiont (ie, a commensal microorganism that is
potentially pathogenic under certain conditions), a nosocomial pathogen and a leading …

Neonatal BSIs continue to decrease due to enhanced infection control and prevention
techniques. However, many challenges remain, including emerging bacterial and fungal …

Abstract Healthcare-Related Infections (ARs) account for one third of infant mortality. IRAS
are acquired infections that occur during hospitalization and are often caused by Gram …

Introduction Healthcare systems in developing countries faced significant challenges during
COVID-19, grappling with limited resources and staffing shortages. Assessment of the …

Background Linezolid is commonly used to treat severe and/or resistant Gram-positive
infections. Few studies have assessed its pharmacokinetic (PK) target attainment in …

L'antibiorésistance représente un problème majeur de santé publique en France et dans le
monde (1). Les souches bactériennes à Cocci Gram positif multi-résistantes, incluant les …

Background Linezolid is commonly used to treat severe and/or resistant Gram-positive
infections. Few studies have assessed its pharmacokinetics/pharmacodynamics (PK/PD) in …

Aims: Recent reports indicate that many coagulase-negative staphylococci (CoNS) strains
are resistant to most antimicrobials used against staphylococcal infections. This study was …